We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.01B
AUM Growth
-$40.3M
Cap. Flow
-$81.7M
Cap. Flow %
-8.12%
Top 10 Hldgs %
53.94%
Holding
5,392
New
831
Increased
1,118
Reduced
1,635
Closed
1,628

Sector Composition

Rank Sector Weight
1 Financials 3.27%
2 Industrials 2.61%
3 Consumer Discretionary 2.36%
4 Materials 2.25%
5 Technology 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCGN icon
3101
Ocugen
OCGN
$434M
$2K ﹤0.01%
8
-5
-38% -$782
OESX icon
3102
Orion Energy Systems
OESX
$80.6M
$2K ﹤0.01%
163
-285
-64% -$3.81K
OFLX icon
3103
Omega Flex
OFLX
$312M
$2K ﹤0.01%
52
-62
-54% -$2.27K
OPOF
3104
DELISTED
Old Point Financial
OPOF
$2K ﹤0.01%
97
-1,106
-92% -$21.9K
OVBC icon
3105
Ohio Valley Banc Corp
OVBC
$205M
$2K ﹤0.01%
72
-328
-82% -$7.21K
PDT
3106
John Hancock Premium Dividend Fund
PDT
$626M
$2K ﹤0.01%
100
-400
-80% -$6.81K
PFSI icon
3107
PennyMac Financial
PFSI
$4.02B
$2K ﹤0.01%
98
-1,578
-94% -$23.9K
PHO icon
3108
Invesco Water Resources ETF
PHO
$2.09B
$2K ﹤0.01%
+100
New +$2.43K
PLSE icon
3109
Pulse Biosciences
PLSE
$3.02B
$2K ﹤0.01%
300
-300
-50% -$1.53K
PPC icon
3110
Pilgrim's Pride
PPC
$6.54B
$2K ﹤0.01%
73
-1,218
-94% -$28.3K
PSLV icon
3111
Sprott Physical Silver Trust
PSLV
$13.2B
$2K ﹤0.01%
+300
New +$2.26K
QNRX
3112
Quoin Pharmaceuticals
QNRX
$9.62M
0
QQQX icon
3113
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.49B
$2K ﹤0.01%
+80
New +$1.48K
RLGT icon
3114
Radiant Logistics
RLGT
$395M
$2K ﹤0.01%
731
-8,249
-92% -$24.9K
RUSHB icon
3115
Rush Enterprises Class B
RUSHB
$6.14B
$2K ﹤0.01%
142
-531
-79% -$5.53K
SCNI
3116
Scinai Immunotherapeutics
SCNI
$1.27M
$2K ﹤0.01%
+5
New +$1.82K
SCZ icon
3117
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
$2K ﹤0.01%
38
+7
+23% +$355
SFBC
3118
Sound Financial Bancorp
SFBC
$111M
$2K ﹤0.01%
73
-352
-83% -$8.61K
SHBI icon
3119
Shore Bancshares
SHBI
$796M
$2K ﹤0.01%
186
-1,700
-90% -$19.9K
SLP icon
3120
Simulations Plus
SLP
$371M
$2K ﹤0.01%
200
-7,640
-97% -$63.4K
SNOA icon
3121
Sonoma Pharmaceuticals
SNOA
$6.89M
$2K ﹤0.01%
2
+1
+100% +$751
SOHO
3122
DELISTED
Sotherly Hotels
SOHO
$2K ﹤0.01%
347
-3,912
-92% -$22.7K
SRV
3123
NXG Cushing Midstream Energy Fund
SRV
$216M
$2K ﹤0.01%
40
+10
+33% +$508
STKS icon
3124
The ONE Group
STKS
$53M
$2K ﹤0.01%
619
+589
+1,963% +$1.48K
STM icon
3125
STMicroelectronics
STM
$50B
$2K ﹤0.01%
230
-270
-54% -$1.94K

Similar funds

Tower Research Capital (TRC)'s Q3 2016 Portfolio in Review

As of Q3 2016, Tower Research Capital (TRC) held 5,392 positions worth $1.01B, down 3.8% from $1.05B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tower Research Capital (TRC) withdrew a net $81.7M in Q3 2016, closing 1,628 positions and reducing 1,635 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 3.3% of assets, down from 6.1% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.7M.

  • Tower Research Capital (TRC)'s largest Q3 2016 buy was Vanguard S&P 500 ETF: 74,203 shares worth $14.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $303M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2016 reduction was State Street Consumer Discretionary Select Sector SPDR ETF, cutting an estimated $24.2M.
  • Tower Research Capital (TRC) fully exited iShares Biotechnology ETF in Q3 2016, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 54% of its $1.01B portfolio in Q3 2016.
  • Tower Research Capital (TRC) opened 831 new positions and closed 1,628 in Q3 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 3.8% quarter-over-quarter to $1.01B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2016, filed 8 Nov 2016.